Australia markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
29.83+0.07 (+0.24%)
At close: 04:00PM EST
30.08 +0.25 (+0.84%)
After hours: 07:46PM EST
Full screen
Loading interactive chart…
  • GuruFocus.com

    Insider Sell Alert: CFO James Mackaness Sells 8,081 Shares of Soleno Therapeutics Inc (SLNO)

    James Mackaness, the Chief Financial Officer of Soleno Therapeutics Inc, has recently made a significant change in his holdings of the company's stock.

  • GlobeNewswire

    Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced, as required by Nasdaq Stock Market rules, the grant of inducement awards to two new employees. The Compensation Committee, consisting of independent members of the Board of Directors of Soleno, approved the grant of non-qualified stock options to purchase 145,000 s

  • GlobeNewswire

    Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

    REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2023. Third Quarter 2023 and Recent Corporate Highlights Announced positive statistically significant top-line data from the randomized withdrawal period of Study C602, a long-t